Form EFFECT Aadi Bioscience, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | October 1, 2021 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Noah Holdings Limited Files 2023 Annual Report on Form 20-F
- MDJM LTD Launches New Cultural Business and Partners with Chinese Artist, Mingyuan Chen, to Bridge Eastern and Western Cultures
- Leqembi® revenue totaled JPY 2.83 billion in the first quarter 2024
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
